StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Pharma-Bio Serv's free cash flow for the twelve months ending Jul 31, 2026 was -$421.36K. For fiscal 2025 it was -$221.53K. The highest annual figure on record is $5.41M in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Oct 31, 2025-$221.53K–
FY2024Oct 31, 2024-$726.44K-138.6%
FY2023Oct 31, 2023$1.88M+228.6%
FY2022Oct 31, 2022$573.19K-27.8%
FY2021Oct 31, 2021$794.00K-45.6%
FY2020Oct 31, 2020$1.46M–
FY2019Oct 31, 2019-$2.27M-163.0%
FY2018Oct 31, 2018$3.60M–
FY2017Oct 31, 2017-$979.64K–
FY2016Oct 31, 2016-$1.10M-3733.8%
FY2015Oct 31, 2015$30.24K-99.0%
FY2014Oct 31, 2014$3.12M-42.2%
FY2013Oct 31, 2013$5.41M+138.0%
FY2012Oct 31, 2012$2.27M+12.6%
FY2011Oct 31, 2011$2.02M+379.1%
FY2010Oct 31, 2010$420.92K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026$59.50K-74.6%
Q2 FY2026CQ1 2026Apr 30, 2026-$367.63K–
Q1 FY2026CQ4 2025Jan 31, 2026-$392.55K–
Q4 FY2025CQ3 2025Oct 31, 2025$279.32K–
Q3 FY2025CQ2 2025Jul 31, 2025$234.49K–
Q2 FY2025CQ1 2025Apr 30, 2025-$305.85K–
Q1 FY2025CQ4 2024Jan 31, 2025-$429.49K-159.2%
Q4 FY2024CQ3 2024Oct 31, 2024-$78.59K-125.4%
Q3 FY2024CQ2 2024Jul 31, 2024-$672.24K-170.3%
Q2 FY2024CQ1 2024Apr 30, 2024-$700.74K–
Q1 FY2024CQ4 2023Jan 31, 2024$725.13K-16.4%
Q4 FY2023CQ3 2023Oct 31, 2023$310.02K-4.7%
Q3 FY2023CQ2 2023Jul 31, 2023$956.77K–
Q2 FY2023CQ1 2023Apr 30, 2023-$250.87K-126.1%
Q1 FY2023CQ4 2022Jan 31, 2023$867.80K+99.7%
Q1 FY2022CQ4 2021Jul 31, 2022$325.23K–
Q2 FY2022CQ1 2022Apr 30, 2022-$1.10M-288.5%
Q4 FY2021CQ3 2021Oct 31, 2021$961.23K+191.2%
Q3 FY2021CQ2 2021Jul 31, 2021$434.61K-64.1%
Q2 FY2021CQ1 2021Apr 30, 2021-$1.19M–
Q1 FY2021CQ4 2020Jan 31, 2021$585.62K-61.1%
Q4 FY2020CQ3 2020Oct 31, 2020$330.04K–
Q3 FY2020CQ2 2020Jul 31, 2020$1.21M–
Q2 FY2020CQ1 2020Apr 30, 2020-$1.58M–
Q1 FY2020CQ4 2019Jan 31, 2020$1.50M–
Q4 FY2019CQ3 2019Oct 31, 2019-$548.94K-239.8%
Q3 FY2019CQ2 2019Jul 31, 2019-$636.70K-137.8%
Q2 FY2019CQ1 2019Apr 30, 2019-$858.68K-661.5%
Q1 FY2019CQ4 2018Jan 31, 2019-$220.80K-116.2%
Q4 FY2018CQ3 2018Oct 31, 2018$392.66K-33.1%
Q3 FY2018CQ2 2018Jul 31, 2018$1.69M–
Q2 FY2018CQ1 2018Apr 30, 2018$152.93K–
Q1 FY2018CQ4 2017Jan 31, 2018$1.37M–
Q4 FY2017CQ3 2017Oct 31, 2017$587.24K–
Q3 FY2017CQ2 2017Jul 31, 2017-$518.95K–
Q2 FY2017CQ1 2017Apr 30, 2017-$952.60K–
Q1 FY2017CQ4 2016Jan 31, 2017-$95.33K–
Q4 FY2016CQ3 2016Oct 31, 2016-$258.99K–
Q3 FY2016CQ2 2016Jul 31, 2016-$420.47K–

More Pharma-Bio Serv figures

See a number that looks wrong?